Gene · 2045
Papers1,016
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,016
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics-guided identification of blood-entering bioactive components and candidate responsive targets of Shugan Jianpi Tiaochang Pill against colorectal adenoma. | Phytomedicine | 2026 | 42607381 | PubTator, text mining | PubMed |
| Multi-Ancestry Genome-Wide Association with Fine-Mapping Identifies Novel Loci for Pigment Dispersion Syndrome and Pigmentary Glaucoma. | Ophthalmol Glaucoma | 2026 | 42508691 | PubTator, text mining | PubMed |
| Methylation-based biomarkers from thin-prep cytology test samples for early detection of cervical cancer: application and clinical potential. | Clin Epigenetics | 2026 | 42169140 | PubTator, text mining | PubMed |
| HPV E6/E7 mRNA vs. HPV DNA in co-testing with ThinPrep cytology for cervical cancer screening: a prospective observational diagnostic accuracy study of methylation biomarkers. | J Gynecol Oncol | 2026 | 42135963 | PubTator, text mining | PubMed |
| miR-196a-5p affects the progression of polycystic ovary syndrome by targeting EPHA7. | J Mol Histol | 2026 | 42018244 | PubTator, text mining | PubMed |
| Integrated Immune and Molecular Profiling Identifies Prognostic Subgroups and Therapeutic Targets in Chondrosarcoma. | Int J Mol Sci | 2026 | 41752158 | PubTator, text mining | PubMed |
| Single-Cell Analysis Reveals Epithelial Heterogeneity and Tumor Microenvironment Characteristics During the Malignant Progression of Colorectal Cancer. | Biomedicines | 2026 | 41751270 | PubTator, text mining | PubMed |
| Oligoclonal B cell expansion and passenger fusion genes predict response to Nivolumab in recurrent ovarian cancer: phase II Kyoto trial. | Cancer Immunol Immunother | 2026 | 41591474 | PubTator, text mining | PubMed |
| Primary Cutaneous CD30-Positive Lymphoproliferative Disorder With Gamma-Delta T-Cells: A Molecular-Annotated Case With a Classic Clinical Appearance and Behavior. | J Cutan Pathol | 2026 | 41387293 | PubTator, text mining | PubMed |
| Clinical significance and biological function of miR-3613-3p in glioma. | Neurol Res | 2026 | 40890969 | PubTator, text mining | PubMed |
| Chidamide impedes the progression of non-small cell lung cancer by inhibiting the METTL3/EPHA7 pathway. | J Chemother | 2026 | 40586624 | PubTator, text mining | PubMed |
| Ephrin Receptors and Ephrin Ligands in Uveal Melanoma: A Big Data Analysis Using Web Resources. | Int J Mol Sci | 2025 | 41516312 | PubTator, text mining | PubMed |
| Histone-, Receptor-, and Integrin-Related Gene Products and ADAM28 as Relevant to B-Cell Acute Lymphoblastic Leukemia (B-ALL). | Curr Issues Mol Biol | 2025 | 41020821 | PubTator, text mining | PubMed |
| A predictive model for evaluating the efficacy of immunotherapy in non-small-cell lung cancer patients: A real-world study. | J Int Med Res | 2025 | 40891808 | PubTator, text mining | PubMed |
| Mechanistic Insights and Clinical Implications of ELK1 in Solid Tumors: A Narrative Review. | Cells | 2025 | 40862737 | PubTator, text mining | PubMed |
| From thought to action: The organization of spinal projecting neurons. | Cell Rep | 2025 | 40818073 | PubTator, text mining | PubMed |
| A mutational process signature and genomic alterations associated with outcome and immunogenicity in cancers with brain metastasis. | Front Immunol | 2025 | 40808963 | PubTator, text mining | PubMed |
| The development and initial findings of a DISGUST scale. | Front Hum Neurosci | 2025 | 40741295 | PubTator, text mining | PubMed |
| Ephrin-A5 or EphA7 stimulation is anti-proliferative for human rhabdomyosarcoma in vitro. | Skelet Muscle | 2025 | 40426233 | PubTator, text mining | PubMed |
Calcifying pseudoneoplasm of the neuraxis progressing to G5/PDGFRA subgroup glioblastoma in a United States Army veteran with a history of head trauma and germline POT1 and EPHB2 mutations: illustrative case. | J Neurosurg Case Lessons | 2025 | 40388884 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2045/papers